Loading...
MDA logo

MedApp S.A.WSE:MDA Stock Report

Market Cap zł57.5m
Share Price
zł0.23
zł0.0032
7.1k% overvalued intrinsic discount
1Y45.6%
7D0.9%
1D
Portfolio Value
View

MedApp S.A.

WSE:MDA Stock Report

Market Cap: zł57.5m

MedApp (MDA) Stock Overview

Engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. More details

MDA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

MDA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

MedApp S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for MedApp
Historical stock prices
Current Share Pricezł0.23
52 Week Highzł0.37
52 Week Lowzł0.068
Beta1.06
1 Month Change-22.82%
3 Month Change-4.17%
1 Year Change45.57%
3 Year Change-41.03%
5 Year Change-75.48%
Change since IPO155.56%

Recent News & Updates

Analysis Article Feb 04

A Look At The Intrinsic Value Of MedApp S.A. (WSE:MDA)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedApp fair value estimate is zł0.14 Current share price of...

Recent updates

Analysis Article Feb 04

A Look At The Intrinsic Value Of MedApp S.A. (WSE:MDA)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedApp fair value estimate is zł0.14 Current share price of...
Analysis Article Mar 26

Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge

MedApp S.A. ( WSE:MDA ) shareholders are no doubt pleased to see that the share price has bounced 26% in the last...
Analysis Article Jan 29

Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?

MedApp S.A. ( WSE:MDA ), is not the largest company out there, but it received a lot of attention from a substantial...
Analysis Article Mar 12

Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
Analysis Article Jan 18

MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?

Most readers would already be aware that MedApp's (WSE:MDA) stock increased significantly by 16% over the past month...
Analysis Article Nov 26

Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years

MedApp S.A. (WSE:MDA) shareholders might understandably be very concerned that the share price has dropped 39% in the...

Shareholder Returns

MDAPL Healthcare ServicesPL Market
7D0.9%1.3%2.7%
1Y45.6%-6.2%32.5%

Return vs Industry: MDA exceeded the Polish Healthcare Services industry which returned -6.1% over the past year.

Return vs Market: MDA exceeded the Polish Market which returned 32.5% over the past year.

Price Volatility

Is MDA's price volatile compared to industry and market?
MDA volatility
MDA Average Weekly Movement17.2%
Healthcare Services Industry Average Movement5.9%
Market Average Movement5.3%
10% most volatile stocks in PL Market11.0%
10% least volatile stocks in PL Market3.1%

Stable Share Price: MDA's share price has been volatile over the past 3 months compared to the Polish market.

Volatility Over Time: MDA's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Polish stocks.

About the Company

FoundedEmployeesCEOWebsite
20108David Odrakiewiczmedapp.pl

MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D.

MedApp S.A. Fundamentals Summary

How do MedApp's earnings and revenue compare to its market cap?
MDA fundamental statistics
Market capzł57.53m
Earnings (TTM)-zł1.18m
Revenue (TTM)zł5.50m
10.5x
P/S Ratio
-48.6x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDA income statement (TTM)
Revenuezł5.50m
Cost of Revenuezł3.30m
Gross Profitzł2.20m
Other Expenseszł3.38m
Earnings-zł1.18m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Aug 14, 2026

Earnings per share (EPS)-0.0047
Gross Margin39.96%
Net Profit Margin-21.52%
Debt/Equity Ratio4.9%

How did MDA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/14 17:24
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedApp S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adrian KowollikEast Value Research GmbH